PBI18 ESTIMATION OF THE HEALTHCARE RESOURCE UTILIZATION (HCRU) COSTS IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA RECEIVING TISAGENLECLEUCEL: A MICRO-COSTING STUDY IN THE UK AND FRANCE
Abstract
Authors
H. Yang Q. Ma X. Chai J. Zhang E.Q. Wu E. Jousseaume D. Kuzan Y. Hao E. Duteil K. Jewitt